You just read:

FDA Approves Expanded Indication for Qudexy® XR (topiramate) Extended-Release Capsules to Include Prophylaxis of Migraine Headache in Adults and Adolescents

News provided by

Upsher-Smith Laboratories, Inc.

30 Mar, 2017, 09:00 ET